Biomet Profile (Biomaterials): Global Market Share Analysis by Region, SWOT, Product Pipeline & Financials

Biomet is one of the five largest orthopedic implant manufacturers in the world, with distribution in the U.S., Europe, Asia and a number of emerging markets. Throughout its history, the company has also expanded into areas such as sports medicine and dental medical devices. As of 2011, Biomet distributed products in approximately 90 countries across the globe, earning revenues in the billions. This report is a comprehensive overview of Biomet's business activities with an in-depth analysis of the company's market share and presence in global orthopedic large joint reconstructive device markets.

The information covered includes:

• An overview of the company history and current product divisions
• A summary of corporate financial metrics
• A review of recently approved products and the results of preliminary clinical trials
• An in-depth review of the strengths, weaknesses opportunities and threats (SWOT) to the company's orthopedic biomaterials divisions
• A detailed look at the market share and performance of each division in various countries across the U.S., Europe and Asia. Whenever possible, market share and division revenues are examined by individual country for each region of the globe.

The key product areas covered in this report include:

• Hip Reconstruction
• Knee Reconstruction

The countries covered in this report include:

• U.S.
• Germany
• France
• U.K.
• Spain
• Italy
• Benelux
• Scandinavia
• Switzerland
• Austria
• Portugal
• Japan
• Australia
• South Korea